ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigms ACL Phase 2 Clinical Trial Success
Published: 14/11/17, 08:38am (AEST)•3 pages